Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study

por de Haan, Freek, Boon, Wouter P. C., Amaratunga, Chanaki, Dondorp, Arjen M.
Publicado 2022

Market Formation in a Global Health Transition

por de Haan, Freek, Moors, Ellen H.M., Dondorp, Arjen M., Boon, Wouter P.C.
Publicado 2021

Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors

por Strohm, Lea, Hehakaya, Charisma, Ranschaert, Erik R., Boon, Wouter P. C., Moors, Ellen H. M.
Publicado 2020

Levelling the Translational Gap for Animal to Human Efficacy Data

por Ferreira, Guilherme S., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., van Meer, Peter J. K.
Publicado 2020

Preferred Islet Delivery Device Characteristics and Implantation Strategies of Patients With Type 1 Diabetes

por Tol, Maarten C., de Bont, Denise F. A., Boon, Wouter P. C., de Koning, Eelco J. P., van Apeldoorn, Aart A.
Publicado 2023

Exploring health practitioners’ acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo

por de Haan, Freek, Onyamboko, Marie A., Fanello, Caterina I., Woodrow, Charles J., Lubell, Yoel, Boon, Wouter P. C., Dondorp, Arjen M.
Publicado 2015

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe

por Ebbers, Hans C., Langedijk, Joris, Bouvy, Jacoline C., Hoekman, Jarno, Boon, Wouter P. C., de Jong, Jean Philippe, De Bruin, Marie L.
Publicado 2015

Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam

por Cao, Van Anh Thi, Nguyen, Thieu Quang, Le Quyen, Duong, Boon, Wouter P. C., Moors, Ellen H. M., Dondorp, Arjen M., de Haan, Freek, Amaratunga, Chanaki
Publicado 2023

A standardised framework to identify optimal animal models for efficacy assessment in drug development

por S. Ferreira, Guilherme, Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., Gispen-de Wied, Christine C., Schellekens, Huub, van Meer, Peter J. K.
Publicado 2019

Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development

por Ferreira, Guilherme S., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., Gispen-de Wied, Christine C., Schellekens, Huub, van Meer, Peter J. K.
Publicado 2019

Toward Responsible Artificial Intelligence in Long-Term Care: A Scoping Review on Practical Approaches

por Lukkien, Dirk R M, Nap, Henk Herman, Buimer, Hendrik P, Peine, Alexander, Boon, Wouter P C, Ket, Johannes C F, Minkman, Mirella M N, Moors, Ellen H M
Publicado 2021

Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion

por de Haan, Freek, Amaratunga, Chanaki, Thi, Van Anh Cao, Orng, Long Heng, Vonglokham, Manithong, Quang, Thieu Nguyen, Lek, Dysoley, Boon, Wouter P. C., Dondorp, Arjen M., Moors, Ellen H. M.
Publicado 2023

Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs

por Ferreira, Guilherme S., Dijkstra, Francis M., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Schellekens, Huub, Moors, Ellen H. M., van Meer, Peter J. K., Stuurman, Frederik E., van Gerven, Joop M. A.
Publicado 2023

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso

por Guissou, Rosemonde M., Amaratunga, Chanaki, de Haan, Freek, Tou, Fatoumata, Cheah, Phaik Yeong, Yerbanga, R. Serge, Moors, Ellen H. M., Dhorda, Mehul, Tindana, Paulina, Boon, Wouter P. C., Dondorp, Arjen M., Ouédraogo, Jean Bosco
Publicado 2023

Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.

por Tindana, Paulina, de Haan, Freek, Mokuolu, Olugbenga Ayodeji, Guissou, Rosemonde, Bolarinwa, Oladimeji Akeem, Ouedraogo, Jean Bosco, Tou, Fatoumata, Boon, Wouter P.C, Moors, Ellen H.M, Dondorp, Arjen M, Dhorda, Mehul, Amaratunga, Chanaki, Cheah, Phaik Yeong
Publicado 2021

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

por de Haan, Freek, Bolarinwa, Oladimeji Akeem, Guissou, Rosemonde, Tou, Fatoumata, Tindana, Paulina, Boon, Wouter P. C., Moors, Ellen H. M., Cheah, Phaik Yeong, Dhorda, Mehul, Dondorp, Arjen M., Ouedraogo, Jean Bosco, Mokuolu, Olugbenga A., Amaratunga, Chanaki
Publicado 2021